King of Japan Ganoderma
Natural health product licensed in Canada
- Other names
- Japanese Six Kind Reishi Extract
- Licence holder
- Wing Quon Enterprises Ltd.
- NPN or DIN-HM
- 80039735
- Status
- Active licence
- Licence date
- 11 February 2013
- Revision date
- 28 December 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ganoderma applanatum Source : En entier Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | Not specified | Not calculated |
| Ganoderma applanatum Source : En entier | 100 mg | Not calculated |
| Ganoderma sinense Source : En entier Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | Not specified | Not calculated |
| Ganoderma sinense Source : En entier | 100 mg | Not calculated |
| Ganoderma lucidum Source : En entier | 50 mg | Not calculated |
| Ganoderma lucidum Source : En entier Extraction ratio : 10:1 Dry plant equivalent : 500 mg | Not specified | Not calculated |
Non-medicinal ingredients
Amidon de riz, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Traditional Chinese Medicine (TCM) to nourish the Heart and strengthen qi and blood to treat Heart and Spleen deficiencies that manifest in insomnia, forgetfulness, fatigue, listlessness and poor appetite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use in the case with excess symptoms.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. If you suffer from an immune system disorder (e.g. Crohn's disease, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, HIV/AIDS, etc.) or if you are taking immunosuppressants, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80039735
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging